Caseware UK (AP4) 2023.0.135 2023.0.135 The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.The company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime. The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies (see note 3).2025-05-210000Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Investments in non-derivative instruments that are equity to the issuer are measured: at fair value with changes recognised in the Statement of comprehensive income if the shares are publicly traded or their fair value can otherwise be measured reliably; at cost less impairment for all other investments. Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income. For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the company would receive for the asset if it were to be sold at the reporting date.2025-05-21No description of principal activitytruetrue2024-01-0100truetruefalse 07974198 2024-01-01 2024-12-31 07974198 2023-01-01 2023-12-31 07974198 2024-12-31 07974198 2023-12-31 07974198 c:Director1 2024-01-01 2024-12-31 07974198 c:RegisteredOffice 2024-01-01 2024-12-31 07974198 d:CurrentFinancialInstruments 2024-12-31 07974198 d:CurrentFinancialInstruments 2023-12-31 07974198 d:ShareCapital 2024-12-31 07974198 d:ShareCapital 2023-12-31 07974198 c:OrdinaryShareClass1 2024-01-01 2024-12-31 07974198 c:OrdinaryShareClass1 2023-01-01 2023-12-31 07974198 c:OrdinaryShareClass1 2024-12-31 07974198 c:OrdinaryShareClass1 2023-12-31 07974198 c:EntityNoLongerTradingButTradedInPast 2024-01-01 2024-12-31 07974198 c:FRS102 2024-01-01 2024-12-31 07974198 c:Audited 2024-01-01 2024-12-31 07974198 c:FullAccounts 2024-01-01 2024-12-31 07974198 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07974198 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07974198 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

img6751.png






Financial Statements
CMS Peripherals Limited
For the year ended 31 December 2024





































Registered number: 07974198
 
CMS Peripherals Limited
 

Company Information


Director
Tom Burke 




Registered number
07974198



Registered office
2nd Floor
15 Worship Street

United Kingdom

E02A 2DT




Independent auditor
Grant Thornton
Chartered Accountants & Statutory Auditors

13 - 18 City Quay

Dublin 2




 
CMS Peripherals Limited
 

Contents



Page
Statement of financial position
1
Notes to the financial statements
2 - 4

 
CMS Peripherals Limited
Registered number:07974198

Statement of financial position
As at 31 December 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 5 
1
1

Net assets
  
1
1


Capital and reserves
  

Called up share capital 
 6 
1
1

Shareholders' funds
  
1
1


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 

Tom Burke
Director

Date: 21 May 2025

The notes on pages 2 to 4 form part of these financial statements.

Page 1
 
CMS Peripherals Limited
 
 
Notes to the financial statements
For the year ended 31 December 2024

1.


General information

CMS Peripherals Limited ("the Company") is a limited company which is incorporated and registered at 2nd Floor, Worship Street, United Kingdom, E02A 2DT.    

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgment in applying the company's accounting policies (see note 3).

 
2.2

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. 

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.
Investments in non-derivative instruments that are equity to the issuer are measured:
∙at fair value with changes recognised in the Statement of comprehensive income if the shares are publicly traded or their fair value can otherwise be measured reliably;
∙at cost less impairment for all other investments.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income. 

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract. 

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the company would receive for the asset if it were to be sold at the reporting date.
Page 2
 
CMS Peripherals Limited
 

Notes to the financial statements
For the year ended 31 December 2024

2.Accounting policies (continued)


2.2
Financial instruments (continued)

Financial assets and liabilities are offset and the net amount reported in the Statement of financial position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.3

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, inclusive of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.


3.


Judgments in applying accounting policies and key sources of estimation uncertainty

There have been no significant judgments or estimates included in the preparation of the financial statements.


4.


Employees




The Company has no employees other than the directors, who did not receive any remuneration (2023: £Nil).



5.


Debtors: Amounts falling due within one year

2024
2023
£
£


Other debtors
1
1


Page 3
 
CMS Peripherals Limited
 
 
Notes to the financial statements
For the year ended 31 December 2024

6.


Share capital

2024
2023
£
£
Authorised, allotted, called up and fully paid



1 (2023: 1) Ordinary share of £1.00
1
1



7.


Related party transactions

The Company has availed of the exemptions in FRS102 paragraph 33.1A which allows non-disclosure of transactions between two or more members of a group, provided that any subsidiary which isn't a party to the transaction is wholly owned by such a member.
There were no other related party transactions such as are required to be disclosed under FRS102 Section 33.


8.


Controlling party

The Company's immediate controlling party and parent undertaking is Storit Limited, a company registered in the Republic of Ireland.
Consolidated accounts are prepared by Storit Limited and are publicly available at the Companies Registration Office, Dublin 1. This is both the smallest and largest company to prepare consolidated financial statements.
The Company's ultimate controlling party is Mr. Frank Salmon, a director and majority shareholder of the parent company, Storit Limited.


9.


Auditor's information

The auditor's report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 21 May 2025 by Cathal Kelly (Senior statutory auditor) on behalf of Grant Thornton.

Page 4